Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.
about
Recent advances in managing and understanding diabetic nephropathyVitamin D and Diabetic Complications: True or False Prophet?Effect of Vitamin D Receptor Activators on Glomerular Filtration Rate: A Meta-Analysis and Systematic ReviewInterplay of vitamin D, erythropoiesis, and the renin-angiotensin systemReview article: vitamin D and inflammatory bowel disease--established concepts and future directionsDiabetic kidney disease: from physiology to therapeuticsCombination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathyUrinary albumin : creatinine ratio predicts prediabetes progression to diabetes and reversal to normoglycemia: role of associated insulin resistance, inflammatory cytokines and low vitamin DRenoprotective effects of long-term oral nicotine in a rat model of spontaneous proteinuriaThe world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system.Vitamin D: newly discovered actions require reconsideration of physiologic requirements.PLK2 Plays an Essential Role in High D-Glucose-Induced Apoptosis, ROS Generation and Inflammation in Podocytes.Vitamin D and chronic kidney diseaseVitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system.Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats.Juxtaglomerular apparatus hyperplasia under dual angiotensin blockade. A footprint of adequate RAS inhibition or a concern for renal fibrosis?Diabetic nephropathy - complications and treatment.Effect of vitamin-D analogue on albuminuria in patients with non-dialysed chronic kidney disease stage 4-5: a retrospective single center study.Emerging drugs for chronic kidney disease.Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study.Oral supplementation with cholecalciferol 800 IU ameliorates albuminuria in Chinese type 2 diabetic patients with nephropathyEnhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency?Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease.Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolismMultiple genes of the renin-angiotensin system are novel targets of Wnt/β-catenin signaling.Vitamin D and vascular disease: the current and future status of vitamin D therapy in hypertension and kidney diseaseThe effect on quality of life of vitamin D administration for advanced cancer treatment (VIDAFACT study): protocol of a randomised controlled trial.Active vitamin D treatment for reduction of residual proteinuria: a systematic review.Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D studyVitamin d receptor activators and clinical outcomes in chronic kidney disease.Nuclear receptors in renal diseaseVitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension.Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney diseaseMolecular mechanism underlying 1,25-dihydroxyvitamin D regulation of nephrin gene expressionPodocyte biology for the bedsideThe use of vitamin D analogues in chronic kidney diseases: possible mechanisms beyond bone and mineral metabolism.The relationship between microvascular complications and vitamin D deficiency in type 2 diabetes mellitusVitamin D therapy in chronic kidney disease and end stage renal disease.The kidney in type 2 diabetes therapy
P2860
Q26745900-462A3822-6782-4100-B2D5-51340BA3E3B3Q26766181-BB87B646-EA9C-4BF9-BD8D-9BB6460064EBQ26774371-D4B2D601-8539-45D8-941F-DDCFFB0A541BQ26822500-212A3C0D-D72D-400E-A94B-7052DC3B1754Q27015639-3D190D90-EFEC-430A-9FC2-38504110CEB6Q27021392-05EDA6FC-C937-4643-A8CD-8631379B8343Q28258849-5AAB4F53-3086-4572-BBAD-A0B80AFF66D6Q28302247-6C145D56-0942-4A56-92F9-E73D2DD34906Q28583340-BB86A990-B99F-4D67-B9AA-71D92221DBF8Q30426517-92FAC8BA-CB08-4AB0-8DC3-768A599E06CDQ33530770-BDF0DBF0-3DCC-48E3-A0DD-121B273FB21BQ33842977-C1774AEC-4953-4239-B96F-E35E65FBCDEEQ33885968-740E7168-84C9-4B2E-8AB5-DE3FE3C465F5Q33979345-B7DDED20-737E-4FFB-94CB-D4EE34A92B4DQ34032089-4C19F914-448D-4788-B4B4-9191464D778EQ34245670-523BF4DA-BF75-4291-8230-D3E9C073B5E9Q34387952-0F0189F3-31E9-4E77-AECE-B7802AEE9B0DQ34408823-18E9701D-CCE4-4CB4-9BC7-478BFA075AC1Q34420383-374F6DD8-DAA7-410F-A657-6D9A1BD813E3Q34457259-93DFFACC-1921-475B-9AD5-C3DB3A5E0010Q34483554-0023501F-68AE-4016-922E-3DC750441FB7Q34500399-2F3BE2C9-D8FA-44C6-A02C-30DC2AAA91D9Q34571836-39F5E14A-97A5-4DBF-AA1B-0085977CB756Q34604473-25C52E77-651F-41FD-95D9-5A3C7FD686A9Q34719267-87933D71-36AE-478E-AA39-61006C371540Q34787805-30AD82A2-DAAE-43D3-95CD-CC5116ED3318Q34797562-2B3D613A-C1A8-42A3-B89E-B528006BB738Q34799604-6B5694E9-4426-4052-B742-02ECE0C2B150Q34912750-7BBE0D89-26F4-4D77-AB70-6E60100D3F1DQ34967905-82DE04CC-D8EE-46FA-B097-BDB54FA53D0AQ35020986-8D337298-9C89-4112-B353-1334C456724EQ35120702-761E6948-320F-464E-A2E6-763AC45DBC7FQ35137622-2AFAC009-63D4-4BE0-9C3F-D9BF73352FB4Q35210184-36B1FA9A-320F-4320-827C-5B23B178BEBCQ35213312-7F0D9B5D-ED39-48F2-94C9-6F0F769A0DF4Q35256633-742F7094-C11C-4C38-9833-7540DBF461C4Q35573698-D6B7B776-6462-4A10-A221-CBF2FD1916D1Q35673714-A0915C6F-0F1E-431A-B05B-679642802BBCQ35758581-47870441-8118-4244-B95A-332F1B474433Q35760302-3A732FF2-89A1-4349-9E60-8156AEE91567
P2860
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Combination therapy with AT1 b ...... f compensatory renin increase.
@en
type
label
Combination therapy with AT1 b ...... f compensatory renin increase.
@en
prefLabel
Combination therapy with AT1 b ...... f compensatory renin increase.
@en
P2093
P2860
P356
P1476
Combination therapy with AT1 b ...... f compensatory renin increase.
@en
P2093
Dilip K Deb
Yan Chun Li
Zhongyi Zhang
P2860
P304
15896-15901
P356
10.1073/PNAS.0803751105
P407
P577
2008-10-06T00:00:00Z